Skip to main content
OpenTrials

Clinical trial condition

Neurofibroma

Explore clinical trials studying Neurofibroma. Study availability and eligibility vary by location and protocol.

238 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Neurofibroma trial results

Active, not recruiting

Study of Aspirin in Patients With Vestibular Schwannoma

NCT03079999

Conditions
Acoustic Neuroma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +29 more
Locations
  • Stanford Otolaryngology/HNS Stanford, California, United States
  • University of Miami Miami, Florida, United States
  • Massachusetts Eye and Ear Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, not recruiting

A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

NCT03611868

Conditions
Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +33 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Highlands Oncology Rogers, Arkansas, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
  • Sarcoma Oncology Research Center Santa Monica, California, United States
View all 21 locations
View Trial Details
Active, not recruiting

FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas

NCT05913037

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Chinese Academy of Medical Sciences & Peking Union Medical College Beijing, Beijing Municipality, China
  • Plastic Surgery Hospital,Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
View all 15 locations
View Trial Details
Active, not recruiting

Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1

NCT04954001

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Principal Investigator Hans Gainesville, Florida, United States
  • John Hopkins All Children Hospital St. Petersburg, Florida, United States
  • Henry Ford Health System Detroit, Michigan, United States
View all 14 locations
View Trial Details
Completed

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

NCT02180867

Conditions
Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma, Atypical Fibroxanthoma, +65 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
View all 381 locations
View Trial Details

Related conditions